Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Appendix A Public Meeting Agendaâ March 20, 2009 COMMITTEE ON COMPARATIVE EFFECTIVENESS RESEARCH PRIORITIZATION PUBLIC AGENDAâFRIDAY, MARCH 20, 2009 FRIDAY, MARCH 20 â PEN SESSION Stakeholderâs Presentations O â Auditorium 8:30am Welcome to Public Session (Dr. Sox) â¢ Mechanisms of announcement (email, website) â¢ Mechanisms of input (meeting and call-in presentations, web submissions) 9:00am Invited presentations from stakeholders â¢ Myrl Weinberg, National Health Council â¢ Nancy Nielsen, American Medical Association â¢ Carmella Bocchino, Americaâs Health Insurance Plans â¢ Ted Buckley, Biotechnology Industry Organization â¢ Mary Jean Schumann, American Nurses Association â¢ William Vaughan, Consumers Union â¢ Ted Epperly, American Academy of Family Physicians â¢ Randy Burkholder, Pharmaceutical Research and Manufacturers of America Question and Answer Session 167
168 INITIAL NATIONAL PRIORITIES FOR CER 10:00am â¢ Naomi Aronson, Blue Cross/Blue Shield Association â¢ Mohammad Akhter, National Medical Association â¢ Dorothy Jeffress, Center for Advancement of Health â¢ Robert Hall, American Academy of Pediatrics â¢ Teresa Lee, Advanced Medical Technology Association â¢ Antonio C. Wolff, American Society of Clinical Oncology â¢ Jack Lewin, American College of Cardiology â¢ Harold Miller, Network for Regional Healthcare Improvement Question and Answer Session 11:00am â¢ Bryan Luce, United BioSource Corporation â¢ Leah Hole-Curry, WA State Health Care Authority â¢ Erick Turner, Oregon health and Science University and Portland VA Medical â¢ Robert Harrison, California Dept of Public Health â¢ Gary Puckrein, National Minority Quality Forum â¢ Marilyn Dix Smith, International Society for Pharmacoeconomics & Outcomes Research â¢ Frederick Grover, Society of Thoracic Surgeons â¢ Douglas Hadley, CIGNA â¢ Adolph Falcon, National Alliance for Hispanic Health â¢ Roger Williams, United States Pharmacopeia Question and Answer Session 12:00pm Lunch Break 1:00pm â¢ Nada Stotland, American Psychiatric Association â¢ Ruth Lubic, Developing Families Center â¢ William Weintraub, American Heart Association â¢ Eugene Rich, Association of American Medical Colleges â¢ Merrill Goozner, Center for Science in the Public Interest â¢ Jeff Allen, Friends of Cancer Research â¢ Les Paul, National Pharmaceutical Council â¢ Steven Bailey, Society for Cardiovascular Angiography and Interventions Question and Answer Session 2:00pm â¢ Clifford Goodman, The Lewin Group â¢ Amy Abernethy, Duke University Medical Center â¢ Katie Orrico, American Association of Neurological Surgeons
APPENDIX A 169 â¢ Christopher Fox, American Association for Dental Research â¢ Amy Miller, Personalized Medicine Coalition â¢ Douglas Peddicord, Association of Clinical Research Organizations â¢ Patrick OâConnor, HealthPartners Research Foundation â¢ Janet Marchibroda, eHealth Initiative Question and Answer Session 3:00pm â¢ J mes Bray, American Psychological Association a â¢ C. Edwin Webb, American College of Clinical Pharmacy â¢ Harrison Spencer, Association of Schools of Public Health â¢ Andrew Sperling, National Alliance on Mental Illness â¢ John Brooks, University of Iowa â¢ Marty Makary, American College of Surgeons â¢ Perry D. Cohen, Parkinson Pipeline Project â¢ Morgan Downey, Health Care Consultancy â¢ Dennis Hart, Focus On Therapeutic Outcomes, Inc. â¢ Eunince K. M. Ernst, Frontier School of Midwifery & Family Nursing â¢ Carolyn Curtis â¢ Patrick OâConnor, American College of Occupational and Environmental Medicine Question and Answer Session 3:50pm Concluding remarks (Dr. Sox) 4:00pm Adjourn